“In FY24, Company’s profitability is expected to improve, driven by growth in Radiopharmaceuticals, Allergy Immunotherapy and CDMO Sterile Injectables businesses.…
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices…
(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters…